Proposed disease activity criteria for mixed connective tissue disease

Abstract

Get full access to this article

View all access options for this article.

References

Sharp GC , Irvin WS , Tan EM , Gould RG , Holman HR Mixed connective tissue disease-an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA) . Am J Med 1972; 52: 148-159.

Bennett RM , O’Connell DJ Mixed connective tissue disease: A clinicopathologic study of 20 cases . Semin Arthritis Rheum 1980; 10: 25-51.

Alarcón-Segovia D. , Cardiel MH Comparison between 3 diagnostic criteria for mixed connective tissue disease. Study of 593 patients . J Rheumatol 1989; 16: 328-334.

Kasukawa R , Sharp GC (eds). Mixed connective tissue disease and anti-nuclear antibodies. Amsterdam: Elsevier ; 1987.

Hassan AB , Gunnarsson I. , Karlsson G. , Klareskog L. , Forslid J. , Lundberg IE Longitudinal study of interleukin-10, tumor necrosis factor-alpha, anti-U1-snRNP antibody levels and disease activity in patients with mixed connective tissue disease. Scand J Rheumatol 2001; 30: 282-289.

Burdt MA , Hoffman RW , Deutscher SL , Wang GS , Johnson JC , Sharp GC Long-term outcome in mixed connective tissue disease: Longitudinal clinical and serologic findings. Arthritis Rheum 1999 ; 42: 899-909.

Minkin W. , Rabhan N. Mixed connective tissue disease. Arch Dermatol 1976; 112: 1535-1538.

Hämeenkorpi R. , Ruuska P. , Forsberg S. , Tiilikainen R. , Mäkitalo R. , Hakala M. More evidence of distinctive features of mixed connective tissue disease. Scand J Rheumatol 1993; 22: 63-68.

Becker TM , Lizzio EF , Merchant B. , Reeves JP , Steinberg AD Increased multiclonal antibody-forming cell activity in the peripheral blood of patients with SLE. Int Arch Allergy Appl Immunol 1981; 66: 293-303.